Oncologix Tech Inc
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologie… Read more
Market Cap & Net Worth: Oncologix Tech Inc (OCLG)
Oncologix Tech Inc (PINK:OCLG) has a market capitalization of $166.25K ($166.25K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41621 globally and #13540 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncologix Tech Inc's stock price $0.00 by its total outstanding shares 1662469227 (1.66 Billion).
Oncologix Tech Inc Market Cap History: 2015 to 2025
Oncologix Tech Inc's market capitalization history from 2015 to 2025. Data shows change from $831.23K to $166.25K (-10.98% CAGR).
Oncologix Tech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncologix Tech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Oncologix Tech Inc's market cap is 0.17 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $831.23K | $4.90 Million | -$2.55 Million | 0.17x | N/A |
| 2016 | $1.50 Million | $4.01 Million | -$1.85 Million | 0.37x | N/A |
| 2017 | $498.74K | $2.85 Million | -$2.37 Million | 0.17x | N/A |
Competitor Companies of OCLG by Market Capitalization
Companies near Oncologix Tech Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Oncologix Tech Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1961 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8548 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8998 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10601 globally with a market cap of $466.44 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1961 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8548 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8998 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩29800.00 |
| #10601 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $466.44 Million | $10.09 |
Oncologix Tech Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Oncologix Tech Inc's market cap moved from $831.23K to $ 166.25K, with a yearly change of -10.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $166.25K | 0.00% |
| 2024 | $166.25K | -96.00% |
| 2023 | $4.16 Million | +31.58% |
| 2022 | $3.16 Million | -79.12% |
| 2021 | $15.13 Million | +1720.00% |
| 2020 | $831.23K | +400.00% |
| 2019 | $166.25K | 0.00% |
| 2018 | $166.25K | -66.67% |
| 2017 | $498.74K | -66.67% |
| 2016 | $1.50 Million | +80.00% |
| 2015 | $831.23K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Oncologix Tech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $166.25K USD |
| MoneyControl | $166.25K USD |
| MarketWatch | $166.25K USD |
| marketcap.company | $166.25K USD |
| Reuters | $166.25K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.